Newton PN, Bond KC. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health 2020; 8: e754–55—In this Comment, the list of signatories has been amended and will be indexed in PubMed, and the appendices have been updated. These corrections have been made as of June 17, 2020.
. 2020 Jun 17;8(7):e900. doi: 10.1016/S2214-109X(20)30255-2
Correction to Lancet Glob Health 2020; 8: e754–55
Issue date 2020 Jul.
© 2020 The Author(s). Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8445353 PMID: 32562646
This corrects the article "COVID-19 and risks to the supply and quality of tests, drugs, and vaccines" on page e754.